$Moderna (MRNA.US)$ $Walvax Biotechnology (300142.SZ)$[AIDS vaccine enters human experimental stage]
▲Moderna AIDS vaccine will start human trials on August 19 and is expected to be completed in the spring of 2023, using mRNA technology similar to the new crown vaccine.
▲Moderna has two candidate HIV vaccines, mRNA-1644 and mRNA-1644v2-Core. These two vaccines have passed preliminary safety tests before they were first used in humans.
▲The new crown epidemic has accelerated the maturity of mRNA vaccine technology, and this technology is also a technology that can achieve mass production as soon as possible. Several other companies are also developing AIDS vaccines. Some candidate vaccines are currently or are about to enter clinical trials.
Looking forward to Watson's breakthroughs in other infectious diseases, just do international mRNA fast-follow.
102355763 : This AIDS vaccine news doesn’t seem to help. Price continues to drop. Hope that Temasek pumps another 250 million into Pfizer and Moderna
Winn Winn : mRNA is a new industry. It may help humans overcome diseases in the future, and in terms of vaccines, to deal with COVID-19, which mutates so fast, only mRNA is strong enough and fast enough
QMengColdJoke : vir is more likely. thanks to WSB vir is not a safe price to buy…
Deathz : trend reversing. buyback time